Revenue
2019
2020
2021
2022
2023
2024
2025
Cresco Labs Inc. (CRLBF)
Price$0.7371Cached quote
Net income
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Revenue | $655.8M | $724.3M | $770.9M | $842.7M | $821.7M | $476.3M | $128.5M |
| Gross profit | $324.6M | $364.5M | $362.4M | $407.0M | $406.3M | $206.7M | $45.6M |
| Gross margin | 49.49% | 50.32% | 47.01% | 48.30% | 49.45% | 43.40% | 35.50% |
| Operating expenses | $352.6M | $257.2M | $450.2M | $491.3M | $623.7M | $230.2M | $98.3M |
| Operating income | −$28.0M | $107.3M | −$87.8M | −$84.3M | −$217.4M | −$23.5M | −$34.3M |
| Operating margin | −4.27% | 14.81% | −11.39% | −10.00% | −26.45% | −4.93% | −26.65% |
| EBITDA | $20.7M | $166.4M | −$25.3M | −$32.4M | −$178.7M | −$2.1M | −$30.0M |
| EBITDA margin | 3.16% | 22.97% | −3.28% | −3.84% | −21.75% | −0.44% | −23.37% |
| Net income | −$135.4M | −$74.4M | −$179.9M | −$215.8M | −$296.8M | −$92.8M | −$65.3M |
| Net profit margin | −20.65% | −10.28% | −23.33% | −25.61% | −36.13% | −19.48% | −50.81% |
| Basic EPSper basic share | -$0.38 | -$0.22 | -$0.54 | -$0.71 | -$1.22 | -$0.39 | -$0.37 |
| Diluted EPSper diluted share | -$0.38 | -$0.22 | -$0.54 | -$0.71 | -$1.22 | -$0.39 | -$0.37 |
Owners
Reported shareholders
Reported holdings Number of shares
View holders
| Holder | Shares held |
|---|---|
ALBERT D MASON INC | 88.04K |
Ancora Advisors LLC | 48.03K |
HANTZ FINANCIAL SERVICES, INC. | 9.51K |
Strategic Investment Solutions, Inc. /IL | 1.41K |
THOMPSON INVESTMENT MANAGEMENT, INC. | 725 |
MassMutual Private Wealth & Trust, FSB | 200 |
Sterling Capital Management LLC | 132 |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data